Mazisotine

N/A

Report date: 2025/06/06 16:48:32
NME

Base Information

Drug NameMazisotine
Drug Alias NameLY-3556050CNTX-0290
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSomatostatin receptor 4 agonists
TargetsSomatostatin receptor 4
Therapy Area/IndicationsDiabetic peripheral neuropathyLow Back PainDiabetic Neuropathies +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaUnited StatesPoland +[6] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesBoehringer Ingelheim International Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesEli Lilly And Company
Inactive CompaniesN/A
Active IndicationsDiabetic peripheral neuropathyLow Back PainOsteoarthritis
Inactive IndicationsDiabetic Neuropathies

Other Information

ATC CodeN/A
Related LinksN/A